SSYS News & Events

The company said, "The Company is reaffirming its outlook for 2026, as set forth below, which is based on current market conditions and assumes that the impacts of global inflationary pressures, relatively high interest rates, exchange rates, increased tariffs and other supply chain costs do not impede economic activity further. Full year revenue growing to a range of $565 million to $575 million, improving sequentially through the year. Based on current logistics and materials costs, full year non-GAAP gross margins of 46.7% to 47.1%, including approximately $7 million of adverse impact from tariffs and foreign exchange rates relative to 2025. Full year non-GAAP operating expenses ranging from $260 million to $262 million, including approximately $10 million of adverse impact from changes in foreign exchange rates. Full year non-GAAP operating margins in a range of 0.7% to 1.5%. GAAP net loss of $83 million to $67 million, or ($0.95) to ($0.76) per diluted share. Non-GAAP net income of $8 million to $12.5 million, or $0.09 to $0.14 per diluted share. Adjusted EBITDA of $25 million to $30 million, with Adjusted EBITDA margin of 4.5% to 5.0%. Capital expenditures of $20 million to $25 million. Expects to generate positive operating cash flow subject to uncertainty related to foreign exchange rates and tariffs." Revenue consensus $564.48M.

Reports Q1 revenue $132.7M, consensus $131.82M. "Our first quarter results reflect the resilience of our operating model in a measured spending environment, demonstrated by positive adjusted EBITDA and operating cash flow," said Dr. Yoav Zeif, CEO of Stratasys. "Recurring revenue from consumables and customer support continued to provide stability, while Stratasys Direct delivered strong 23% organic growth year-over-year across a diverse range of industrial applications, led by drone customers. As we look forward, our current pipeline in high requirement applications, especially in defense, continues to build as we gain confidence in our ability to win prominent contracts in 2026 and beyond."

Stratasys unveiled a slate of new application-driven software capabilities, materials, and platform enhancements designed to empower manufacturers to push additive manufacturing beyond concept models and into production parts faster than ever. Stratasys will enable organizations to move the production of more parts and tools from traditional methods into additive workflows, by streamlining design and ease of use, improving reliability, and expanding materials and platform capabilities. This approach will dramatically increase speed and performance while reducing costs. The J850 Core printer expands the PolyJet(TM) technology lineup with a lower-cost system built for engineering teams focused on functional prototyping. It gives customers access to PolyJet performance and materials without paying for full-color capabilities. These advancements hit the sweet spot between capability and cost for teams that want speed and reliability at a more practical price point. The system is planned to be open for booking by the end of April.Stratasys and Shin-Etsu are introducing P3 MED Silicone 25A, the first biocompatible true silicone for 3D printing patient-specific medical devices and low-volume production parts, available exclusively on Origin printers. Fully certified to ISO 10993 standards, the material delivers authentic silicone properties such as elasticity, durability, and resistance to heat, chemicals, and aging. This combination overcomes many challenges traditionally associated with 3D printing true silicone.

Stratasys announced that it has expanded its portfolio of additive manufacturing solutions across multiple industries with the introduction of new software and materials that expand applications of existing systems and improve ease of use for customers. New materials include: ULTEM 1010 filament for the F3300(R) printer, and PolyJet ToughONE White for Stratasys J3/J5 printers, along with a new Measurement-Based Warped Modeling software addition to GrabCAD Print Pro.